Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues

被引：31
|
作者：
Parmentier, Jean-Gilles [1 ]
Portevin, Bernard [1 ]
Golsteyn, Roy M. [2 ]
Pierre, Alain [2 ]
Hickman, John [2 ]
Gloanec, Philippe [1 ]
De Nanteuil, Guillaume [1 ]
机构：
[1] Inst Rech Servier, Med Chem Div D, F-92150 Suresnes, France
[2] Inst Rech Servier, Div Cancerol, F-78290 Croissy Sur Seine, France
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 03期
关键词：
Hymenialdisine; CHK1; inhibitor; CHECKPOINT; KINASES;
D O I：
10.1016/j.bmcl.2008.12.001
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of thieno[3,2-b]pyrroloazepinones derivatives related to Hymenialdisine were prepared and tested for CHK1 inhibitory activity. Nanomolar inhibitions were achieved when electron-withdrawing substituents were introduced at position 3 of the thiophene ring. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：841 / 844
页数：4
相关论文
共 50 条
  • [41] BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1
    Li, Lemin
    Wang, Linchen
    Liu, Dian
    Zhao, Yongchao
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [42] mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells
    Koppenhafer, Stacia L.
    Goss, Kelli L.
    Terry, William W.
    Gordon, David J.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (12) : 2676 - 2688
  • [43] Novel Insights into Chk1 Regulation by Phosphorylation
    Goto, Hidemasa
    Kasahara, Kousuke
    Inagaki, Masaki
    CELL STRUCTURE AND FUNCTION, 2015, 40 (01) : 43 - 50
  • [44] Chk1 and claspin potentiate PCNA ubiquitination
    Yang, Xiaohong H.
    Shiotani, Bunsyo
    Classon, Marie
    Zou, Lee
    GENES & DEVELOPMENT, 2008, 22 (09) : 1147 - 1152
  • [45] Enhancing CHK1 inhibitor lethality in glioblastoma
    Tang, Yong
    Dai, Yun
    Grant, Steven
    Dent, Paul
    CANCER BIOLOGY & THERAPY, 2012, 13 (06) : 379 - 388
  • [46] Chk1 is required to maintain Claspin stability
    Chini, C. C. S.
    Wood, J.
    Chen, J.
    ONCOGENE, 2006, 25 (30) : 4165 - 4171
  • [47] Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitors
    Li, Gaoquan
    Tao, Zhi-Fu
    Tong, Yunsong
    Przytulinska, Magdalena K.
    Kovar, Peter
    Merta, Philip
    Chen, Zehan
    Zhang, Haiying
    Sowin, Thomas
    Rosenberg, Saul H.
    Lin, Nan-Horng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (23) : 6499 - 6504
  • [48] Chk1 degradation as a therapeutic target in cancer
    不详
    CANCER BIOLOGY & THERAPY, 2005, 4 (10) : 1045 - 1045
  • [49] Inhibition of Chk1 by activated PKB/Akt
    King, FW
    Skeen, J
    Hay, N
    Shtivelman, E
    CELL CYCLE, 2004, 3 (05) : 634 - 637
  • [50] Chk1 is required for spindle checkpoint function
    Zachos, George
    Black, Elizabeth J.
    Walker, Mark
    Scott, Mary T.
    Vagnarelli, Paola
    Earnshaw, William C.
    Gillespie, David A. F.
    DEVELOPMENTAL CELL, 2007, 12 (02) : 247 - 260
12345